Tau expression correlated with breast cancer sensitivity to taxanes-based neoadjuvant chemotherapy

Taxane resistance in breast cancer: Mechanisms, predictive biomarkers and circumvention strategies

(2012) S. Murray et al.   CANCER TREATMENT REVIEWS

Clinicopathological characters of triple negative breast cancer

(2010) Xin Zhou et al.   Chinese Journal of Cancer Research

BCIRG 001 Molecular Analysis: Prognostic Factors in Node-Positive Breast Cancer Patients Receiving Adjuvant Chemotherapy

(2010) C. Dumontet et al.   CLINICAL CANCER RESEARCH

Evaluation of Microtubule-Associated Protein-Tau Expression As a Prognostic and Predictive Marker in the NSABP-B 28 Randomized Clinical Trial

(2009) Lajos Pusztai et al.   JOURNAL OF CLINICAL ONCOLOGY

Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial

(2008) George Pentheroudakis et al.   BREAST CANCER RESEARCH AND TREATMENT

Tumour molecular subtyping according to hormone receptors and HER2 status defines different pathological complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer

(2008) Alfonso Sánchez-Muñoz et al.   Clinical & Translational Oncology

Predictive markers of response to neoadjuvant chemotherapy in breast cancer

(2008) Mallika Tewari et al.   SURGICAL ONCOLOGY-OXFORD